Lilly's retatrutide GLP-1 delivers average weight loss of 50 pounds - USA Today

1 sources1 storiesFirst seen 9/30/2026Score32Mixed Progress

Single Source

Bigness

Coverage

Recency

Engagement

Velocity

Confidence

Clipability

Polarization

Claims

Contradictions

Breakthrough

Sentiment Mix

Positive0%

Neutral100%

Negative0%

Geography

North America

Expert Signals

Politics - Google News US Headlines

source • 1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Lilly's retatrutide GLP-1 delivers average weight loss of 50 pounds - USA Today.

Supported by 1 story

Lilly's retatrutide GLP-1 delivers average weight loss of 50 pounds USA TodayEli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial cnbc.com‘Godzilla' of weight-loss drugs could provide other important health benefits The GuardianLilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs.

Supported by 1 story

tirzepatide 15 mg in adults with obesity and type 2 diabetes Eli LillyBlockbuster retatrutide trial signals a ‘new high-water mark' for weight-loss drugs Scientific American

Supported by 1 story